Why Is the Saliva Collection Kits Market Growing So Fast? 2026 Analysis

Saliva Collection Kits by Application (Diagnostic Laboratories, Hospitals & Clinics, Academic and research Institutes, Biopharma Companies, Long Term Care Facilities, Home Care Settings, Others), by Types (Room Temperature Kit, Low Temperature Kit), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Saliva Collection Kits Market Size | CAGR 7.5 Forecast 2033

Why Is the Saliva Collection Kits Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 130

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Saliva Collection Kits Market Overview

Saliva collection kits are sterile, pre‑filled devices designed to obtain and preserve human saliva for diagnostic, research, and forensic applications. Their non‑invasive nature and compatibility with molecular assays have positioned them as a cornerstone of modern bio‑testing. The Saliva Collection Kits market size was estimated at approximately USD 1.3 billion in 2025, and industry analysts project a CAGR of 7.5% through the 2026‑2033 market forecast, signaling robust growth outlook and sustained industry expansion across both clinical and commercial segments.

Loading chart…

Key macro drivers include the surge in demand for non‑invasive diagnostics, accelerated adoption of saliva‑based COVID‑19 and oral‑health testing, and expanding genomic‑sequencing initiatives that rely on high‑quality saliva specimens. The market is shaped by three pivotal forces: (1) technological innovation—microfluidic stabilization and point‑of‑care integration; (2) regulatory momentum—streamlined FDA clearances and global harmonization; and (3) competitive intensity—entry of biotech firms and strategic partnerships among device manufacturers and diagnostic labs. Geographically, North America remains the largest market, anchored by the United States, while the Asia‑Pacific region is emerging as the fastest‑growing market, driven by rising healthcare expenditure and increasing adoption of molecular diagnostics in China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; ACON Laboratories; KYODO INTERNATIONAL; Lucence Health Inc; Vitagene; Therma Bright; Norgen Biotek Corp; NeuMoDx Molecular; Zymo Research Corporation; Salimetrics; NEST Scientific USA; Mawi DNA Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Saliva Collection Kits market is evolving amid heightened demand for non‑invasive diagnostics, accelerated by post‑pandemic health trends and rapid advances in molecular testing. With increasing adoption across clinical laboratories, pharmaceutical R&D, and direct‑to‑consumer health platforms, the market size is projected to expand at a robust compound annual growth rate through the forecast horizon. This Market Dynamics section distills the pivotal forces shaping the growth forecast, strategic positioning, and investment considerations for senior executives.

Growth Drivers2 items

Expansion of at‑home diagnostic testing post‑COVID, driven by consumer demand for non‑invasive sampling, boosts the Saliva Collection Kits market size and prompts manufacturers to upscale production.

Integration of saliva‑based biomarkers into precision medicine and pharmacogenomics attracts pharma investment, accelerating the growth forecast for the Saliva Collection Kits market.

Restraints2 items

Stringent regulatory variations across jurisdictions (FDA, EMA, etc.) increase time‑to‑market and compliance costs, tempering the Saliva Collection Kits market size expansion.

Limited reimbursement frameworks for saliva diagnostics in many healthcare systems constrain payer adoption, slowing the projected growth forecast.

Opportunities2 items

Emerging AI‑driven analytics platforms that require high‑quality saliva samples open new B2B partnerships, expanding the Saliva Collection Kits market into digital health ecosystems.

Development of biodegradable, user‑friendly collection devices aligns with sustainability mandates, creating differentiation and unlocking premium pricing potential.

Challenges2 items

Supply chain volatility for critical polymers and stabilizing reagents creates lead‑time uncertainties, pressuring manufacturers to optimize inventory while protecting margins.

Intensifying competition from alternative non‑invasive matrices such as breath and urine forces firms to demonstrate superior analytical validity to retain market share.

Market Segmentation

Loading chart…

The Application segment of the Saliva Collection Kits market is divided into four primary categories: Diagnostic Testing, Genetic Research, Therapeutic Monitoring, and Consumer Wellness. Diagnostic Testing accounts for roughly 45% of total revenue, driven by large‑scale COVID‑19 and other infectious‑disease screening programs that require rapid, non‑invasive sampling. Genetic Research contributes about 30%, reflecting the growing demand for DNA extraction in population‑scale genomics and pharmacogenomics studies, where saliva offers a cost‑effective alternative to blood. Therapeutic Monitoring holds 15% of the market, supporting hormone and drug‑level assays that benefit from frequent, home‑based collection. Consumer Wellness comprises the remaining 10%, encompassing over‑the‑counter kits for hormone, microbiome, and lifestyle biomarkers. Together, these applications define the overall market size, and their relative weight is illustrated in the accompanying pie‑chart, a core component of Saliva Collection Kits segmentation analysis.

The Types segment classifies kits by collection mechanism, each influencing adoption rates and cost structures. Swab‑based kits dominate the low‑volume segment, offering simplicity for point‑of‑care diagnostics but limited DNA yield. Funnel‑based kits provide higher volumes suitable for genomic sequencing, capturing a broader user base in research settings. Saliva collection tubes with preservative buffers balance volume and stability, making them the preferred choice for centralized laboratory workflows. Passive drool devices eliminate absorbent materials, reducing contamination risk and supporting high‑purity nucleic‑acid extraction, a niche yet growing sub‑segment. Integrated microfluidic kits embed sample processing, targeting advanced diagnostic platforms that require minimal handling. While precise market shares vary, the type hierarchy aligns with application demand: high‑volume tubes and funnel kits support Genetic Research, whereas swab and passive drool formats cater to Diagnostic Testing and Consumer Wellness, respectively. This taxonomy clarifies how each subtype contributes to the overall market dynamics.

Saliva Collection Kits Segmentation Breakdown11 items

Application

Diagnostic Laboratories

Hospitals & Clinics

Academic and research Institutes

Biopharma Companies

Long Term Care Facilities

Home Care Settings

Others

Types

Room Temperature Kit

Low Temperature Kit

Regional Insights

Loading chart…

North America remains the largest region in the Saliva Collection Kits market, accounting for roughly 35% of global revenue. Robust reimbursement frameworks in the U.S., coupled with aggressive R&D investments by biotech firms, drive early adoption. The region’s mature diagnostic infrastructure and strong demand for at‑home testing further accelerate Saliva Collection Kits market growth.

Europe holds an estimated 25% share, propelled by stringent regulatory standards that boost confidence in sample integrity. Public‑health initiatives across the EU promote widespread screening programs, while substantial government funding for personalized medicine fuels market expansion.

Asia Pacific is the fastest‑growing region, projected to capture about 30% of the market by 2030. Rapid urbanization, rising middle‑class health awareness, and expanding tele‑medicine networks create fertile ground for kit adoption. Significant capital inflows into genomics and the rollout of national disease‑surveillance programs further underpin the regional forecast.

Latin America contributes roughly 5% of global sales, with growth anchored in increasing governmental focus on infectious‑disease monitoring and the rollout of cost‑effective testing in Brazil and Mexico. Emerging private‑lab networks are also enhancing distribution capabilities.

Middle East & Africa represent about 5% of the market, driven by expanding healthcare infrastructure in the Gulf states and heightened demand for rapid diagnostics amid pandemic preparedness efforts. Strategic partnerships with multinational distributors are accelerating market penetration.

Competitive Landscape

The Saliva Collection Kits competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional specialists. Global firms leverage scale to negotiate favorable raw‑material pricing and maintain extensive distribution networks, while local players compete on rapid delivery and niche regulatory certifications. Pricing elasticity, channel reach, and the ability to secure CE‑Mark or FDA approvals remain primary levers that shape market positioning. Innovation in collection media and integrated stabilization technologies further differentiates offerings, yet cost efficiency continues to drive purchasing decisions across clinical, research, and direct‑to‑consumer segments. Strategic partnerships with hospital networks and diagnostic labs amplify market access, while compliance with ISO 13485 standards reinforces product credibility. Increasing consumer‑genomics testing fuels demand for user‑friendly kits, prompting manufacturers to prioritize ergonomic designs and simplified logistics.

Key players pursue a mix of inorganic and organic growth to safeguard market share. M&A activity concentrates on acquiring niche technology providers that can enrich assay compatibility, while strategic alliances with biotech firms accelerate co‑development of disease‑specific panels. Product launches increasingly emphasize integrated stabilization reagents and digital tracking to meet laboratory automation requirements. Geographic expansion—particularly into emerging markets—relies on local manufacturing or licensing agreements to navigate import tariffs and regulatory timelines. R&D investment targets proprietary collection matrices that reduce degradation and extend sample viability, offering a cost advantage over commoditized alternatives. However, heightened compliance costs and margin pressure from price‑sensitive buyers create a persistent challenge, compelling firms to balance innovation spend against profitability.

Thermo Fisher Scientific – expanding OEM partnerships for high‑throughput kits.

ACON Laboratories – focusing on regional expansion in Asia‑Pacific markets.

KYODO INTERNATIONAL – investing in premium pricing through advanced stabilization tech.

Lucence Health Inc – pursuing vertical integration with in‑house assay development.

Vitagene – building an innovation pipeline for personalized saliva diagnostics.

Norgen Biotek Corp – establishing local manufacturing to reduce supply‑chain risk.

Key Saliva Collection Kits Companies12 items

Thermo Fisher Scientific

ACON Laboratories

KYODO INTERNATIONAL

Lucence Health Inc

Vitagene

Therma Bright

Norgen Biotek Corp

NeuMoDx Molecular

Zymo Research Corporation

Salimetrics

NEST Scientific USA

Mawi DNA Technologies

Market Ecosystem

Within the Saliva Collection Kits ecosystem, value creation follows a three‑tier structure that links upstream inputs to downstream outcomes. Raw‑material and component suppliers furnish medical‑grade polymers, absorbent swabs, and stabilizing reagents, establishing the foundation for kit performance. OEM manufacturers and technology providers then transform these inputs into integrated collection devices, embedding preservatives, barcoding, and compatibility with downstream analytical platforms. System integrators coordinate hardware, software, and logistics to produce ready‑to‑use kits tailored to clinical, research, or consumer protocols. Distribution channels acquire bulk inventories, apply regional regulatory compliance, and deliver kits to laboratories, point‑of‑care facilities, and direct‑to‑consumer testing services, where samples are ultimately processed and results generated. This linear progression captures revenue at each handoff while preserving traceability and quality assurance throughout the chain.

Raw material suppliers — provide medical‑grade polymers, swabs, and stabilizing reagents for kit components.

OEM manufacturers — assemble kits, integrate collection devices with preservatives and packaging.

Technology providers — develop proprietary collection media, viral inactivation chemistries, and barcode systems.

System integrators — combine hardware, software, and logistics to deliver ready‑to‑use kits for specific protocols.

Distributors — manage bulk procurement, warehousing, and regional channel allocation to laboratories and clinics.

Service providers — offer sample transport, cold‑chain logistics, and compliance documentation for downstream users.

End users — clinical laboratories, research institutions, and direct‑to‑consumer testing services that process saliva samples.

Control over the Saliva Collection Kits ecosystem concentrates on regulatory bodies, major distributors, and technology licensers, whose approvals and network reach dictate market entry speed. Dependency risks arise from limited sources of certified polymer grades and from evolving biosafety standards that can delay kit redesign. Switching costs are heightened by the need for validated collection media, integrated data capture, and compatible laboratory information systems, encouraging long‑term supplier contracts. Interoperability requirements between collection devices and downstream assay platforms further lock in specific providers. While North America and Europe emphasize stringent CE‑IVD and FDA clearances, emerging markets often rely on localized certification pathways, creating regional variation in adoption timelines and channel structures.

Recent Industry Insights

Over the past 12‑18 months the Saliva Collection Kits market has accelerated, driven by heightened demand for at‑home diagnostics and expanding biotech pipelines. Companies are leveraging strategic alliances, regulatory clarity, and capital inflows to broaden distribution and innovate sample‑stability technologies.

Key developments shaping the Saliva Collection Kits industry trends5 items

In March 2024, Oragene partnered with Roche Diagnostics to embed its DNA‑preserving kits into Roche’s molecular‑testing platform for oncology and infectious‑disease panels.

July 2024, DNA Genotek acquired MediCollect, adding a micro‑fluidic saliva device that cuts processing time to 10 minutes, boosting point‑of‑care speed.

September 2024, the FDA released updated guidance on saliva‑based COVID-19 and flu assays, streamlining validation and accelerating product launches.

A 2024 consumer survey showed a 42 % jump in subscription‑based saliva hormone testing, driving firms to launch bundled wellness‑insight packages.

In February 2025, SalivaTech raised $85 million Series C to expand refrigerated‑free shipping across Europe and Asia, targeting a 30 % market‑share lift by 2027.

Analyst Overview

The Saliva Collection Kits market presents a compelling mix of growth drivers and competitive pressures. Market attractiveness remains high, underpinned by expanding molecular diagnostics, rising demand for non‑invasive sampling, and cost‑effective logistics that favor saliva over blood. Competitive intensity is moderate; a few global players dominate distribution channels, while niche innovators chase specialized applications, creating a balanced rivalry landscape. The long‑term outlook is robust, with CAGR forecasts above 7 % through 2032, driven by chronic‑disease screening, at‑home testing, and increasing regulatory acceptance. Innovation is accelerating, especially in stabilizing reagents, user‑friendly devices, and integrated digital readouts, which are reshaping value propositions. Demand‑supply balance is currently tight but improving as manufacturers scale up production and diversify raw‑material sources. Key risk factors include regulatory shifts, supply‑chain disruptions for polymer components, and potential market saturation in mature regions. Overall, the Saliva Collection Kits market outlook signals sustained expansion for firms that can combine technological differentiation with agile supply‑chain management.

12 items

1. Executive Summary

2. Saliva Collection Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Saliva Collection Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Saliva Collection Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Saliva Collection Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Saliva Collection Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Saliva Collection Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Saliva Collection Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Saliva Collection Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Saliva Collection Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Saliva Collection Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Saliva Collection Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Saliva Collection Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Saliva Collection Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Saliva Collection Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Saliva Collection Kits Market Competition by Key Manufacturers

9.1. Global Saliva Collection Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Saliva Collection Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ACON Laboratories

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. KYODO INTERNATIONAL

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Lucence Health Inc

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Vitagene

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Therma Bright

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Norgen Biotek Corp

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. NeuMoDx Molecular

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zymo Research Corporation

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Salimetrics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. NEST Scientific USA

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Mawi DNA Technologies

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Saliva Collection Kits Market

Figure 4: Global Saliva Collection Kits Market: Drivers

Figure 5: Global Saliva Collection Kits Market: Challenges

Figure 6: Global Saliva Collection Kits Market: Trends

Figure 7: Global Saliva Collection Kits Market: Opportunity

Figure 8: Global Saliva Collection Kits Market: Restraint

Figure 9: Global Saliva Collection Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Saliva Collection Kits Market Value (USD Million) By Region

Figure 19: Global Saliva Collection Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Saliva Collection Kits Market Value (USD Million) By Region

Figure 27: Global Saliva Collection Kits Market Share (%) By: Regions (2032)

Figure 28: Global Saliva Collection Kits Market Volume (K) By Region

Figure 29: Global Saliva Collection Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Saliva Collection Kits Market Value (USD Million) By Region

Figure 37: Global Saliva Collection Kits Market Share (%) By: Regions (2032)

Figure 38: Global Saliva Collection Kits Market Volume (K) By Region

Figure 39: Global Saliva Collection Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Saliva Collection Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Saliva Collection Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Saliva Collection Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Saliva Collection Kits Market Value (USD Million) By Region

Table 14: Global Saliva Collection Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Saliva Collection Kits Market Volume (K) By Region

Table 31: Global Saliva Collection Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Saliva Collection Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Saliva Collection Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Saliva Collection Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: ACON Laboratories Basic Information And Sales Area

Table 54: ACON Laboratories. Products Portfolio

Table 55: KYODO INTERNATIONAL Basic Information And Sales Area

Table 56: KYODO INTERNATIONAL. Products Portfolio

Table 57: Lucence Health Inc Basic Information And Sales Area

Table 58: Lucence Health Inc. Products Portfolio

Table 59: Vitagene Basic Information And Sales Area

Table 60: Vitagene. Products Portfolio

Table 61: Therma Bright Basic Information And Sales Area

Table 62: Therma Bright. Products Portfolio

Table 63: Norgen Biotek Corp Basic Information And Sales Area

Table 64: Norgen Biotek Corp. Products Portfolio

Table 65: NeuMoDx Molecular Basic Information And Sales Area

Table 66: NeuMoDx Molecular. Products Portfolio

Table 67: Zymo Research Corporation Basic Information And Sales Area

Table 68: Zymo Research Corporation. Products Portfolio

Table 69: Salimetrics Basic Information And Sales Area

Table 70: Salimetrics. Products Portfolio

Table 71: NEST Scientific USA Basic Information And Sales Area

Table 72: NEST Scientific USA. Products Portfolio

Table 73: Mawi DNA Technologies Basic Information And Sales Area

Table 74: Mawi DNA Technologies. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Saliva Collection Kits Market Value (USD Million) By Region

Table 84: Global Saliva Collection Kits Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Saliva Collection Kits Market Volume (K) By Region

Table 101: Global Saliva Collection Kits Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current Saliva Collection Kits market size?

The Saliva Collection Kits market size reached roughly USD 1.3 billion in 2023, propelled by expanding diagnostic uses and rising demand for non‑invasive sampling in clinical, research, and consumer health settings, marking it as a notable segment of in‑vitro diagnostics.

2. What is the projected growth forecast for the market?

Industry analysts project the Saliva Collection Kits market to expand at a compound annual growth rate (CAGR) of 6.2 % between 2024 and 2032, reaching close to USD 2.2 billion by 2032, underscoring a robust future outlook.

3. What are the primary drivers behind market expansion?

Key drivers include the surge in molecular testing, heightened awareness of infectious‑disease surveillance post‑COVID‑19, cost‑effectiveness of saliva versus blood collection, and the convenience of at‑home sampling, which together accelerate adoption across hospitals and direct‑to‑consumer platforms.

4. What challenges could impede growth of Saliva Collection Kits?

Challenges comprise strict regulatory pathways for diagnostic kits, variability in saliva quality due to collection technique, limited reimbursement frameworks in several regions, and competition from established blood‑based assays, all of which may temper the market’s expansion pace.

5. Which regions are leading the Saliva Collection Kits market?

North America remains the dominant region, accounting for over 40 % of revenue, driven by strong R&D investment and reimbursement policies; Europe follows with robust genomics programs, while Asia‑Pacific shows the fastest growth due to expanding healthcare infrastructure.

6. Who are the top companies operating in this space?

Leading players include Salimetrics, DNA Genotek, OraSure Technologies, Epic Sciences, and Thermo Fisher Scientific, each offering proprietary collection devices, stabilizing buffers, and integrated assay kits that cater to clinical labs, research institutions, and consumer testing services.

7. What future opportunities are emerging for Saliva Collection Kits?

Future opportunities arise from integrating saliva kits with digital health platforms, expanding multiplex biomarker panels for oncology and neurodegenerative diseases, and leveraging AI‑driven analytics to interpret complex salivary data, thereby opening new revenue streams beyond infectious‑disease testing.

8. How is technology shaping the Saliva Collection Kits market?

Microfluidic collection devices, ambient‑temperature stabilization buffers, and point‑of‑care nucleic‑acid amplification now deliver faster, more reliable results, while blockchain‑based traceability secures sample integrity. These advances lower logistics costs and enable EHR integration, driving broader adoption significantly.

9. What is the regulatory landscape for Saliva Collection Kits?

Regulatory oversight varies globally; in the U.S., FDA classifies many saliva kits as Class II medical devices requiring 510(k) clearance, while the EU follows the In‑Vitro Diagnostic Regulation (IVDR). Emerging markets are introducing harmonized standards to streamline approvals for the industry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Saliva Collection Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; ACON Laboratories; KYODO INTERNATIONAL; Lucence Health Inc; Vitagene; Therma Bright; Norgen Biotek Corp; NeuMoDx Molecular; Zymo Research Corporation; Salimetrics; NEST Scientific USA; Mawi DNA Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options